Major Players in the South Korea Blepharitis Market | Top Companies 2026

Major Players in the South Korea Blepharitis Market

The South Korea Blepharitis Market is defined by recognized pharmaceutical companies offering innovative ophthalmic solutions, including specialized eye drops, ointments, and lid hygiene products. Key players in the market include Samil Pharmaceutical Co., Ltd., Hanmi Pharmaceutical Co., Ltd., Novartis Korea, and Santen Korea.

South Korea Blepharitis Market Overview

According to 6Wresearch, the market for blepharitis in South Korea is currently undergoing tremendous growth, on account of the rising prevalence of the condition and the growing need for effective treatment solutions. Blepharitis is a chronic inflammatory disease that affects the eyelids and can lead to secondary ocular surface issues.

The market is currently being driven by the growing trend of using advanced topical antibiotics, corticosteroids, and specialized eyelid hygiene therapies. In addition, several initiatives have been put in place by the government to ensure improved healthcare services and expanded universal health coverage for ophthalmic conditions.

Competitive Landscape

The competitive landscape of the South Korea blepharitis Industry encompasses several global and domestic manufacturers, especially in the ophthalmology and specialized drug sectors. The significant market position of the dominant companies is sustained with continued investment in R&D, which helps in the development of innovative drugs, thus catering to the growing need for effective blepharitis drugs.

Below is a list of leading players operating in the South Korea Blepharitis Market:

1. Samil Pharmaceutical Co., Ltd.

Samil is a traditional leader, offering a comprehensive portfolio of anti-inflammatory and antibiotic eye drops used for treating eyelid margin inflammation.

2. Hanmi Pharmaceutical Co., Ltd.

Hanmi is recognized for its advanced R&D and specialized formulations that support the chronic management of ocular surface and eyelid diseases.

3. Novartis Korea

Novartis leads with innovative ophthalmic therapies and anti-inflammatory agents that have become a standard of care for patients with ocular inflammation.

4. Santen Korea

Santen is a specialized ophthalmic company that dominates the market with its high-quality range of treatments for blepharitis.

5. AbbVie Korea

AbbVie remains a dominant force, providing leading ophthalmic products and ointments catering to a large patient base requiring advanced therapy.

6. Huons Co., Ltd.

Huons is one of Korea's most trusted pharmaceutical brands, providing a wide range of eye drops and lubricant treatments.

7. Kukje Pharma Co., Ltd.

Kukje Pharma is a key player in the development of topical antibiotics and steroids used in the clinical management of chronic blepharitis.

8. Bausch + Lomb Korea

Bausch + Lomb focuses on eyelid hygiene and protein-cleansing solutions, contributing to the broader landscape of lid margin disease care.

9. Daewoong Pharmaceutical Co., Ltd.

Daewoong maintains a strong presence through a robust distribution network and its own portfolio of anti-infective and anti-rheumatic solutions.

10. Taejoon Pharm Co., Ltd.

Taejoon is a dedicated ophthalmic specialist, producing a variety of domestically developed drops and gels used extensively for treating eyelid inflammation.

Major Players in the South Korea Blepharitis Market: FAQs